Claire O'Hanlon is a doctoral candidate at the Pardee RAND Graduate School and an assistant policy analyst at RAND. She was previously a research assistant at University of Chicago Medicine, where she worked on validating prognostic models of life expectancy in older diabetic patients. During this time, O'Hanlon was also a business development intern at Knopp Biosciences, a biotechnology start-up, where she developed a pharmacoeconomic model of the progression and costs of Parkinson's disease under user-defined assumptions. O'Hanlon also worked as a laboratory technician at Duquesne University, where she designed MRI-visible delivery agents for water-insoluble drugs.
O'Hanlon holds a master of public policy degree from the University of Chicago Harris School, a certificate in health administration and policy from the University of Chicago, and a B.S. in engineering from Harvey Mudd College. Her interests include health policy, health care technology, and science and technology policy.
O'Hanlon CE, Amede KG, O'Hear MR, Janjic JM, "NIR-Labeled Perfluoropolyether Nanoemulsions for Drug Delivery and Imaging," Journal of Fluorine Chemistry, 137:27-33, 2012